Join Now

Category Archives: BioUtah News

Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration

By Natalie Themm | Published February 6, 2025

Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration

| Tagged | Comments Off on Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration

Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay

By Natalie Themm | Published February 6, 2025

Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay

| Tagged | Comments Off on Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay

Tasso and ARUP Laboratories Announce Partnership, Combined Offering for Decentralized Clinical Research Biomarker Testing

By Natalie Themm | Published February 6, 2025

The partnership combines Tasso’s clinical grade blood collection solutions, such as the Tasso+ device pictured above, with ARUP’s gold standard testing capabilities to streamline and accelerate decentralized clinical research.

| Tagged | Comments Off on Tasso and ARUP Laboratories Announce Partnership, Combined Offering for Decentralized Clinical Research Biomarker Testing

PhotoPharmics Announces Leadership Transition in Clinical & Scientific Advisory Board

By Natalie Themm | Published February 6, 2025

PhotoPharmics Announces Leadership Transition in Clinical & Scientific Advisory Board

| Tagged | Comments Off on PhotoPharmics Announces Leadership Transition in Clinical & Scientific Advisory Board

Owlet Unveils ‘Owlet360’ – Turning Infant Health Data Into Peace of Mind for Parents

By Natalie Themm | Published January 30, 2025

This new subscription service, exclusive to Owlet users, gives parents a deeper, personalized understanding of their baby’s development, health, and sleep trends.

| Tagged | Comments Off on Owlet Unveils ‘Owlet360’ – Turning Infant Health Data Into Peace of Mind for Parents

Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference

By Natalie Themm | Published January 30, 2025

Opening plenary session features latest fetal fraction amplification research

| Tagged | Comments Off on Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference

Life Sciences Day on the Hill 2025

By Natalie Themm | Published January 30, 2025

The Capitol Rotunda was filled with exhibits from over 25 local life sciences companies.

Also posted in Life Sciences Events | | Tagged | Comments Off on Life Sciences Day on the Hill 2025

Kelvyn Cullimore Joins KSL Radio’s Inside Sources

By admin | Published January 24, 2025

SALT LAKE CITY, January 23, 2025—Today BioUtah president and CEO Kelvyn Cullimore joined KSL Radio’s Inside Sources to discuss the life sciences industry in the State of Utah. Hosted by Maura Carabello and Adam Gardiner, Inside Sources daily broadcast covers political issues affecting Utah. Today, Carabello and Gardiner interviewed Cullimore to spotlight Utah’s life sciences industry and […]

| Comments Off on Kelvyn Cullimore Joins KSL Radio’s Inside Sources

Ultradent Donating to Southern California Fire Relief

By Natalie Themm | Published January 14, 2025

Ultradent Donating to Southern California Fire Relief

| Tagged | Comments Off on Ultradent Donating to Southern California Fire Relief

Canyon Labs Announces Strategic Acquisition of iuvo BioScience’s Lab Services and Consulting Businesses to Expand End-to-End Development Solutions

By Natalie Themm | Published January 9, 2025

Transaction positions iuvo BioScience for continued growth as an industry leader in ophthalmic clinical research

| Tagged | Comments Off on Canyon Labs Announces Strategic Acquisition of iuvo BioScience’s Lab Services and Consulting Businesses to Expand End-to-End Development Solutions

Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II)

By Natalie Themm | Published January 9, 2025

Denali expects to submit a Biologics License Application for tividenofusp alfa in early 2025 for regulatory review under the accelerated approval pathway

| Tagged | Comments Off on Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II)

Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical Trials, Targeting High Unmet Needs in Hematologic Malignancies, Small-Cell Lung Cancer, & More

By Natalie Themm | Published January 9, 2025

Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical Trials, Targeting High Unmet Needs in Hematologic Malignancies, Small-Cell Lung Cancer, & More

| Tagged | Comments Off on Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical Trials, Targeting High Unmet Needs in Hematologic Malignancies, Small-Cell Lung Cancer, & More

A Special Thanks To Our Legacy and Platinum Elite Members